DCM
BIOR

Dupont Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Dupont Capital Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-139
Closed -$184K – 1702
2020
Q4 		$184K Sell
139
-11
-7% -$16.1K ﹤0.01% 1147
2020
Q3 		$338K Buy
+150
New +$339K 0.01% 933

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dupont Capital Management's BIOR Position: Q1 2021 in Review

Dupont Capital Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2021, closing a stake of 139 shares — an estimated $184K sold.

Dupont Capital Management first reported a position in BIOR in Q3 2020 and held it in 2 quarters. The position peaked at $338K in Q3 2020. 47 funds tracked by Wall St. Rank hold BIOR as of Q1 2021.

  • Dupont Capital Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Dupont Capital Management sold 139 Biora Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $184K.
  • Dupont Capital Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Dupont Capital Management's Biora Therapeutics, Inc. Common Stock position peaked at $338K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Dupont Capital Management's 13F filing for Q1 2021, filed 29 Apr 2021.